[Management of heart and circulation. 1. Circulatory agents].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000818:Animals; D002110:Caffeine / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000662:veterinary*; D010455:Peptides / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D010455:Peptides; D014662:Vasoconstrictor Agents; D002110:Caffeine; D013806:Theophylline
Die Behandlung von Herz und Kreislauf. 1. Kreislauf mittle